Clinical Study Protocol
Published on 27 Mar 2019
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
in Neuromuscular Disorders and Peripheral Neuropathies
- 12,669 views
- 70 citations















